Sort   by:  
 Page size 
UnknownPrognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.
Not available
S-EPMC3532392 | biostudies-literature
UnknownFaculty Development in Improvement Science: Building Capacity and Expanding Curricula Across an Academic Health Center.
Not available
S-EPMC6919187 | biostudies-literature
UnknownNovel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian Perspective.
Not available
S-EPMC9026432 | biostudies-literature
UnknownEffect of Eplerenone on Diastolic Function in Women Receiving Anthracycline-Based Chemotherapy for Breast Cancer.
Not available
S-EPMC8352029 | biostudies-literature
UnknownUnderstanding breast cancer patients' preference for two types of exercise training during chemotherapy in an unblinded randomized controlled trial.
Not available
S-EPMC2582030 | biostudies-literature
UnknownHR+/HER2- Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review.
Not available
S-EPMC10297170 | biostudies-literature
UnknownPatterns and predictors of exercise behavior during 24 months of follow-up after a supervised exercise program during breast cancer chemotherapy.
Not available
S-EPMC7023725 | biostudies-literature
UnknownNeoadjuvant therapy for breast cancer: updates and proceedings from the Seventh Annual Meeting of the Canadian Consortium for Locally Advanced Breast Cancer
Not available
S-EPMC6209552 | biostudies-literature
UnknownAn asynchronous electronic consent for improving consent in research among patients with cancer.
Not available
S-EPMC12557314 | biostudies-literature
UnknownA Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2-Positive Metastatic Breast Cancer (CCTG IND.229).
Not available
S-EPMC6853090 | biostudies-literature
Sort   by:  
 Page size